FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Remorseful Regulator Leads Reform Fight
- Lightning Round: AT&T, Verizon, Novartis and More
- Lightning Round OT: Alcoa, Weight Watchers and More
- Why Amazon Rules Retail
- Nordic American: Sinking Ship or Titan Tanker?
- Cramer: What Monday’s Housing Number Really Means
- Cramer: Buy These Banks, If...
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
- Lightning Round OT: Knight Capital, Ebix and More
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMERS SOUNDBOARDAdmit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.
CHECK OUT OUR PHOTOSCheck out Cramer on set, back to school, behind the scenes and more.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It's Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money's mobile. Get show highlights sent to your phone.
Text Size 
 |
While Wall Street had feared the worst for health-care stocks, as President Obama set his sights on reform, Cramer said that just one group within the sector would be targeted: HMOs. Any company that got fat feeding at the federal trough is probably in trouble.
Cramer pointed to Medicare’s Advantage program as one government initiative by which health maintenance organizations have profited greatly. He expects Obama’s legislation to curtail that, as well as protect consumers who feel “ripped off” by HMOs.
“This is the most egregious industry of all industries,” Cramer said. “[It] generates gigantic cash flow and really has just done the wrong thing with it consistently.”
Cramer recommended WellPoint [WLP
Loading...
()
] because it has much less exposure to Medicare Advantage than UnitedHealth [UNH
Loading...
()
], Aetna [AET
Loading...
()
] or Humana [HUM
Loading...
()
].
Cramer also endorsed Boston-Scientific [BSX
Loading...
()
], a biotech firm operating outside Obama’s focus, on the successful trial of a new heart device.
Elsewhere in the market, a private-equity firm’s $350 million investment in Office Depot [ODP
Loading...
()
] has eliminated at least one reason for owning Staples [SPLS
Loading...
()
], Cramer said. Just a year ago, ODP was struggling, making a growth in market share for Staples seem inevitable. But with the new cash infusion, the competition between these two retailers is back on.
“That makes me like Staples less,” Cramer said.
Call Cramer: 1-800-743-CNBC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes